carnitine has been researched along with Basal Ganglia Diseases in 1 studies
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipkin, PH | 1 |
| Roe, CR | 1 |
| Goodman, SI | 1 |
| Batshaw, ML | 1 |
1 other study available for carnitine and Basal Ganglia Diseases
| Article | Year |
|---|---|
A case of glutaric acidemia type I: effect of riboflavin and carnitine.
Topics: Amino Acid Metabolism, Inborn Errors; Basal Ganglia Diseases; Carnitine; Cerebral Palsy; Child, Pres | 1988 |